Concepedia

Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome

Michael J. Cavnar, Lin Wang, Vinod P. Balachandran, Cristina R. Antonescu, William D. Tap, Mary Louise Keohan, S. J. Singer, Larissa K. Temple, Garrett M. Nash, Martin R. Weiser,

Annals of Surgical Oncology · 2017 · 82 citations · 28 references

DOIFull text

Open access

Concepts

References

28

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

Ronald P. DeMatteo, Karla V. Ballman, Cristina R. Antonescu et al. · The Lancet · 2009 · 1.4K citations · Full text

, , +11

Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era

Bengt Nilsson, Per Bümming, Jeanne M. Meis‐Kindblom et al. · Cancer · 2005 · 1.3K citations · Full text

, , +13

The Epidemiology of Malignant Gastrointestinal Stromal Tumors: An Analysis of 1,458 Cases from 1992 to 2000

Thomas Tran, Jessica A. Davila, Hashem B. El‐Serag · The American Journal of Gastroenterology · 2005 · 692 citations

, , +16

Lymph Node Metastasis From Soft Tissue Sarcoma in Adults Analysis of Data From a Prospective Database of 1772 Sarcoma Patients

Yuman Fong, Daniel G. Coit, James M. Woodruff et al. · Annals of Surgery · 1993 · 577 citations

, , +14

We Should Desist Using RECIST, at Least in GIST

Robert S. Benjamin, Haesun Choi, Homer A. Macapinlac et al. · Journal of Clinical Oncology · 2007 · 554 citations

, , +17